scholarly journals Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial

2017 ◽  
Vol 177 (4) ◽  
pp. 1024-1032 ◽  
Author(s):  
M. Sticherling ◽  
U. Mrowietz ◽  
M. Augustin ◽  
D. Thaçi ◽  
N. Melzer ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Prime Trial ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Randomized Controlled ◽  
Systemic Treatments ◽  
Acid Esters

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

2017 ◽  
Vol 15 (2) ◽  
pp. 180-186 ◽  
Author(s):  
Peter Weisenseel ◽  
Kristian Reich ◽  
Wiebke Griemberg ◽  
Katharina Merten ◽  
Christine Gröschel ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Plaque Psoriasis ◽  
Efficacy And Safety ◽  
Severe Plaque Psoriasis ◽  
Fumaric Acid Esters ◽  
Acid Esters
Sign in / Sign up

Export Citation Format

Share Document